Thymosin alpha 1 as an immunomodulatory peptide in infection and malignancy
Frontiers in Immunology
2018
Study summary
Comprehensive review of thymosin alpha 1 in antiviral immunity, sepsis, and cancer.
Key findings
Thymosin alpha 1 enhanced innate and adaptive immune signaling across multiple settings.
Study details
Study type
review article
Journal
Frontiers in Immunology
DOI / PubMed
10.3389/fimmu.2018.01539
Year
2018
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
